Literature DB >> 30006734

Current trends in pharmacovigilance: value and gaps of patient reporting.

Pedro Inácio1, Afonso Cavaco2, Marja Airaksinen3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30006734     DOI： 10.1007/s11096-018-0689-6

Source DB:  PubMed          Journal:  Int J Clin Pharm


× No keyword cloud information.
  23 in total

Review 1.  Experiences with adverse drug reaction reporting by patients: an 11-country survey.

Authors:  Florence van Hunsel; Linda Härmark; Shanthi Pal; Sten Olsson; Kees van Grootheest
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

Review 2.  Web-based intensive monitoring: from passive to active drug surveillance.

Authors:  Linda Härmark; Kees van Grootheest
Journal:  Expert Opin Drug Saf       Date:  2011-10-18       Impact factor: 4.250

3.  The organizational framework of community pharmacies in Europe.

Authors:  Sílvia Filipa Martins; J W Foppe van Mil; Filipa Alves da Costa
Journal:  Int J Clin Pharm       Date:  2015-05-28

4.  Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.

Authors:  Cristiano Matos; Linda Härmark; Florence van Hunsel
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

5.  The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015.

Authors:  Florence van Hunsel; Susan de Waal; Linda Härmark
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-05-19       Impact factor: 2.890

Review 6.  Factors affecting patient reporting of adverse drug reactions: a systematic review.

Authors:  Rania Al Dweik; Dawn Stacey; Dafna Kohen; Sanni Yaya
Journal:  Br J Clin Pharmacol       Date:  2016-11-25       Impact factor: 4.335

7.  Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?

Authors:  F Kheloufi; A Default; F Rouby; D Laugier-Castellan; M Boyer; B Rodrigues; J Ponte-Astoul; M J Jean-Pastor; O Blin; J Micallef
Journal:  Eur J Clin Pharmacol       Date:  2017-04-08       Impact factor: 2.953

8.  Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy.

Authors:  Elisabetta Parretta; Concetta Rafaniello; Lara Magro; Anna Coggiola Pittoni; Liberata Sportiello; Carmen Ferrajolo; Annamaria Mascolo; Maurizio Sessa; Francesco Rossi; Annalisa Capuano
Journal:  Expert Opin Drug Saf       Date:  2014-09       Impact factor: 4.250

9.  The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.

Authors:  Leàn Rolfes; Florence van Hunsel; Laura van der Linden; Katja Taxis; Eugène van Puijenbroek
Journal:  Drug Saf       Date:  2017-07       Impact factor: 5.606

10.  WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems.

Authors:  Shanthi N Pal; Chris Duncombe; Dennis Falzon; Sten Olsson
Journal:  Drug Saf       Date:  2013-02       Impact factor: 5.606
View more
  4 in total

1.  Comment on "Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project".

Authors:  Cedric Bousquet; Bissan Audeh; Florelle Bellet; Agnès Lillo-Le Louët
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

2.  Overview of this issue: pharmacovigilance, what is new?

Authors:  Linda Gore Martin; Yolande Hanssens; Vibhu Paudyal
Journal:  Int J Clin Pharm       Date:  2018-08

3.  A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.

Authors:  Ningsheng Wang; Yue Chen; Biqi Ren; Yufang Xiang; Nan Zhao; Xianyan Zhan; Bianling Feng
Journal:  BMC Health Serv Res       Date:  2022-03-08       Impact factor: 2.655

4.  Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era.

Authors:  Renato Ferreira-da-Silva; Inês Ribeiro-Vaz; Manuela Morato; Jorge Junqueira Polónia
Journal:  Int J Clin Pharm       Date:  2021-06-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.